Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) Income from Continuing Operations (2023 - 2024)

Sagimet Biosciences (SGMT) has 2 years of Income from Continuing Operations data on record, last reported at 16201000.0 in Q4 2024.

  • For Q4 2024, Income from Continuing Operations fell 98.74% year-over-year to 16201000.0; the TTM value through Dec 2024 reached 45567000.0, down 63.43%, while the annual FY2025 figure was 51038000.0, 12.01% down from the prior year.
  • Income from Continuing Operations reached 16201000.0 in Q4 2024 per SGMT's latest filing, down from 14619000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 6357000.0 in Q3 2023 and bottomed at 16201000.0 in Q4 2024.